Cargando…
Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study
PURPOSE: To investigate the intra-cameral level of ganciclovir following topical application of ganciclovir gel, 0.15% for cytomegalovirus (CMV) anterior segment infection. DESIGN: Non-randomized, prospective, interventional clinical study. METHODS: Patients with active CMV anterior segment infectio...
Autores principales: | Waduthantri, Samanthila, Zhou, Lei, Chee, Soon-Phaik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788360/ https://www.ncbi.nlm.nih.gov/pubmed/29377953 http://dx.doi.org/10.1371/journal.pone.0191850 |
Ejemplares similares
-
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes
por: Colin, Joseph
Publicado: (2007) -
Aqueous Cytokine Changes Associated with Posner-Schlossman Syndrome with and without Human Cytomegalovirus
por: Li, Jing, et al.
Publicado: (2012) -
Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications
por: Chou, Timothy Y, et al.
Publicado: (2014) -
Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis
por: Wong, John X. H., et al.
Publicado: (2016) -
Long-Term Outcome of Treatment with 2% Topical Ganciclovir Solution in Cytomegalovirus Anterior Uveitis and Corneal Endotheliitis
por: Chen, Po-Jui, et al.
Publicado: (2022)